Home Sustainable Bioproducts Secures $33 Million Series A Funding to Commercialize Innovative Fermentation-Derived Protein

Sustainable Bioproducts Secures $33 Million Series A Funding to Commercialize Innovative Fermentation-Derived Protein

Feb 12, 2019 12:00 CST Updated 12:00

VCBeat (WeChat ID: vcbeat) has learned that Sustainable Bioproducts, a company specializing in sustainable biological products, recently announced it had raised $33 million in its Series A financing round. The round was led by 1955 Capital, with participation from Breakthrough Energy Ventures, ADM Ventures, Danone Manifesto Ventures, and others. The funds will be used to commercialize innovative protein fermentation technology.


Sustainable Bioproducts is a high-tech biotechnology company specializing in innovative protein fermentation technologies, headquartered at the Polsky Center for Entrepreneurship and Innovation in Chicago, USA. The company has revamped and upgraded traditional fermentation techniques to produce proteins that are “highly nutritious and have minimal environmental impact.” According to Sustainable Bioproducts’ official website, this technology aims to artificially “feed” advanced protein-producing microorganisms with common food ingredients, such as starch or glycerol, enabling them to multiply rapidly. The protein produced through this method contains all nine essential amino acids required by the human body, offering exceptionally high nutritional value. Media analyses suggest that this innovation could create a new, sustainable approach to meeting the growing global demand for protein.


“In recent years, the demand for protein has surged exponentially. We believe that innovative fermentation technology can become the most attractive and effective protein solution,” said Chung, Managing Partner at 1955 Capital. “Whether in developed countries across Europe and America or in developing nations in Asia, Africa, and Latin America, the demand for protein will continue to intensify.”


“We have conducted extensive fundamental research on extremophiles found in the volcanic hot springs of Yellowstone National Park, thereby developing effective microbial fermentation methods,” said Thomas Jonas, CEO and Co-Founder of Sustainable Bioproducts. “This work has facilitated the development of innovative fermentation technology capable of producing proteins with exceptionally high nutritional value and minimal environmental impact. With this round of financing, we will explore the commercialization of our innovative protein fermentation technology to promote health for a broader population.”


>>>>

About 1955 Capital


1955 Capital is a global venture capital firm founded in 2015 and headquartered in California, USA. The firm primarily focuses on energy and environmental challenges, food security, and healthcare and education issues in developing countries. Its investment focus is on high-tech companies and startups.

(Compiled by Hu Xuan)